🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07545070
Starting soon Not applicable

The Efficacy of an AI-Based Rehabilitation Treatment in Patients With Anxiety Disorders

NCT07545070 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Mental Health Center
Phase
Not applicable
Started
2026-04-25
Last updated
2026-04-22

Condition(s) studied

Anxiety Disorders

Investigational drug(s) / intervention(s)

AI-based rehabilitation treatment combined with standard treatmentTreatment as Usual (TAU)

AI-based rehabilitation treatment combined with standard treatment: Participants were offered a 3-week psychological intervention , delivered by the AI-based rehabilitation system. The system contains 12 core topics, such as basic knowledge and emotion regulation, cognitive restructuring, behavior activation, interpersonal communication skills, mindfulness and sleep, and relaxation training. The intervention schedule was 4 sessions per week, each lasting approximately 20 minutes, for a total of 12 sessions.

Treatment as Usual (TAU): Both groups will receive treatment as usual, including medication, exercise and psychological education.

Study summary

The trail aimed to test the efficacy of AI-based rehabilitation treatment in patients with anxiety disorders. Specifically, the objective of this trial is to determine whether the AI-based rehabilitation combined with treatment as usual is more effective than treatment as usual alone in improving outcomes in patients with anxiety disorders.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
1\. Subjects with anxiety disorders * Inclusion Criteria: * In accordance with ICD-11 for Anxiety Disorders; * Between the ages of 18-60; * Completed at least 9 years of education; * Ability to use computers or smartphone; * Native Chinese speaker; * Signing informed consent. * Exclusion Criteria: * With severe psychiatric symptoms requiring hospitalization, or unable to complete the required assessment and treatment; * Use of cognitive-enhancing medications within the past 6 months; * With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai Mental Health Center Shanghai Shanghai Municipality

More Shanghai Mental Health Center trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07545070 on ClinicalTrials.gov ↗ ← All trials in China